Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite
Calcium hydroxyapatite can be a significant component of black pigment gallstones. Diverse molecules that bind calcium phosphate inhibit hydroxyapatite precipitation. Because glycine-conjugated bile acids, but not their taurine counterparts, bind calcium phosphate, we studied whether glycochenodeoxy...
Saved in:
Published in | The Journal of clinical investigation Vol. 88; no. 4; pp. 1265 - 1271 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Ann Arbor, MI
American Society for Clinical Investigation
01.10.1991
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Calcium hydroxyapatite can be a significant component of black pigment gallstones. Diverse molecules that bind calcium phosphate inhibit hydroxyapatite precipitation. Because glycine-conjugated bile acids, but not their taurine counterparts, bind calcium phosphate, we studied whether glycochenodeoxycholic acid inhibits calcium hydroxyapatite formation. Glycochenodeoxycholic acid (2 mM) totally inhibited transformation of amorphous calcium phosphate microprecipitates to macroscopic crystalline calcium hydroxyapatite. This inhibition was not mediated by decreased Ca2+ activity. Taurocholic acid (2-12 mM) did not affect hydroxyapatite formation, but antagonized glycochenodeoxycholic acid. Both amorphous and crystalline precipitates contained a surface fraction relatively rich in phosphate. The surface phosphate content was diminish by increasing glycochenodeoxycholic acid concentrations, and this relationship was interpreted as competition between bile acid and HPO4(-4) for binding sites on the calcium phosphate surface. A phosphate-rich crystal surface was associated with rapid transition from amorphous to crystalline states. These results indicate that glycochenodeoxycholic acid prevents transformation of amorphous calcium phosphate to crystalline hydroxyapatite by competitively inhibiting the accumulation of phosphate on the crystal embryo surface. |
---|---|
AbstractList | Calcium hydroxyapatite can be a significant component of black pigment gallstones. Diverse molecules that bind calcium phosphate inhibit hydroxyapatite precipitation. Because glycine-conjugated bile acids, but not their taurine counterparts, bind calcium phosphate, we studied whether glycochenodeoxycholic acid inhibits calcium hydroxyapatite formation. Glycochenodeoxycholic acid (2 mM) totally inhibited transformation of amorphous calcium phosphate microprecipitates to macroscopic crystalline calcium hydroxyapatite. This inhibition was not mediated by decreased Ca2+ activity. Taurocholic acid (2-12 mM) did not affect hydroxyapatite formation, but antagonized glycochenodeoxycholic acid. Both amorphous and crystalline precipitates contained a surface fraction relatively rich in phosphate. The surface phosphate content was diminish by increasing glycochenodeoxycholic acid concentrations, and this relationship was interpreted as competition between bile acid and HPO4(-4) for binding sites on the calcium phosphate surface. A phosphate-rich crystal surface was associated with rapid transition from amorphous to crystalline states. These results indicate that glycochenodeoxycholic acid prevents transformation of amorphous calcium phosphate to crystalline hydroxyapatite by competitively inhibiting the accumulation of phosphate on the crystal embryo surface. Glycochenodeoxycholic acid (2 mM) totally inhibited transformation of amorphous calcium phosphate microprecipitates to macroscopic crystalline calcium hydroxyapatite. This inhibition was not mediated by decreased Ca super(2+) activity. Taurocholic acid (2-12 mM) did not affect hydroxyapatite formation, but antagonized glycochenodeoxycholic acid. Both amorphous and crystalline precipitates contained a surface fraction relatively rich in phosphate. The surface phosphate content was diminished by increasing glycochenodeoxycholic acid concentrations, and this relationship was interpreted as competition between bile acid and HPO super(2) sub(4) super(-) for binding sites on the calcium phosphate surface. A phosphate-rich crystal surface was associated with rapid transition from amorphous to crystalline states. These results indicate that glycochenodeoxycholic acid prevents transformation of amorphous calcium phosphate to crystalline hydroxyapatite by competitively inhibiting the accumulation of phosphate on the crystal embryo surface. |
Author | HIRAKAWA, N GARY WEN SUI-MIN QIU NAN-KANG HONG SOLOWAY, R. D CROWTHER, R. S |
AuthorAffiliation | Department of Internal Medicine, University of Texas Medical Branch, Galveston 77550 |
AuthorAffiliation_xml | – name: Department of Internal Medicine, University of Texas Medical Branch, Galveston 77550 |
Author_xml | – sequence: 1 surname: SUI-MIN QIU fullname: SUI-MIN QIU organization: Univ. Texas medical branch, dep. internal medicine, div. gastroenterology, Galveston TX 77550, United States – sequence: 2 surname: GARY WEN fullname: GARY WEN organization: Univ. Texas medical branch, dep. internal medicine, div. gastroenterology, Galveston TX 77550, United States – sequence: 3 givenname: N surname: HIRAKAWA fullname: HIRAKAWA, N organization: Univ. Texas medical branch, dep. internal medicine, div. gastroenterology, Galveston TX 77550, United States – sequence: 4 givenname: R. D surname: SOLOWAY fullname: SOLOWAY, R. D organization: Univ. Texas medical branch, dep. internal medicine, div. gastroenterology, Galveston TX 77550, United States – sequence: 5 surname: NAN-KANG HONG fullname: NAN-KANG HONG organization: Univ. Texas medical branch, dep. internal medicine, div. gastroenterology, Galveston TX 77550, United States – sequence: 6 givenname: R. S surname: CROWTHER fullname: CROWTHER, R. S organization: Univ. Texas medical branch, dep. internal medicine, div. gastroenterology, Galveston TX 77550, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5404663$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/1655828$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9rFTEUxYNU6mt14QcQspBCF2Pzb_5k4UIetlYKbup6uJNJOikzyZjkPZwv1M9pyjyeCoKrQM7vHO695wydOO80Qm8p-UBpza4elaW0FJy8QBtalk3RMN6coA0hjBay5s0rdBbjIyFUiFKcolNaZYo1G_R0My7Kq0E732v_c1GDH63CoGyPrRtsZ1PECkZldxOeBx_nAZLGc9DKzjZBst5lEO9tCh53y7Oy1y5Z94DToHEK4KLxYVpJbzBMPuSg3b9ikz9-Dksf8jwwZ2PSr9FLA2PUbw7vOfp-_fl--6W4-3Zzu_10VyhBCSk6DbIWtREUJBFCm0r2jCilKGNARMMMAUkrpuuOsx6oFB0RUBnVyc70xvBz9HHNnXfdpHuVNwkwtnOwE4Sl9WDbvxVnh_bB71smy1KW2X9x8Af_Y6djaicblR5HcDqv3NaMci45-S9IKyoyyTJ4uYIq-BiDNsdhKGmfy2-_bm_X8jP77s_pf5Nr21l_f9Ah5jub3I2y8YiVgoiq4vwX-TC_5w |
CODEN | JCINAO |
CitedBy_id | crossref_primary_10_1016_j_actbio_2010_06_031 crossref_primary_10_1016_j_cis_2019_04_011 crossref_primary_10_1016_S0022_2275_20_39170_7 crossref_primary_10_1039_D1BM01239H crossref_primary_10_1080_10408398_2021_1954873 crossref_primary_10_1016_S0022_2275_20_41217_9 crossref_primary_10_1016_j_jcis_2021_01_008 crossref_primary_10_1016_0016_5085_94_90134_1 crossref_primary_10_3390_ma10040334 crossref_primary_10_1002_hep_1840210621 crossref_primary_10_1016_0016_5085_95_90656_8 crossref_primary_10_1016_S0022_2275_20_41489_0 crossref_primary_10_3390_molecules26185531 crossref_primary_10_1111_j_1600_0676_1996_tb00753_x crossref_primary_10_1246_nikkashi_2000_19 crossref_primary_10_1002_hep_1840160526 crossref_primary_10_1111_j_1600_0676_1993_tb00621_x crossref_primary_10_1002_hep_1840160627 crossref_primary_10_1039_D4NR01536C |
ContentType | Journal Article |
Copyright | 1992 INIST-CNRS |
Copyright_xml | – notice: 1992 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7X8 5PM |
DOI | 10.1172/jci115430 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Calcium & Calcified Tissue Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1558-8238 |
EndPage | 1271 |
ExternalDocumentID | 10_1172_JCI115430 1655828 5404663 |
Genre | Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIADDK NIH HHS grantid: AM-16549 |
GroupedDBID | --- -~X .55 .GJ .XZ 08G 08P 08R 29K 2WC 354 36B 3O- 3V. 53G 5GY 5RE 5RS 7RV 7X7 88A 88E 8AO 8F7 8FE 8FH 8FI 8FJ 8R4 8R5 AAKAS AAWTL AAYOK ABFLS ABOCM ABPMR ABPTK ABUWG ACGFO ACIHN ACNCT ACPRK ADBBV ADGIM ADZCM AEAQA AENEX AFCHL AFFNX AFKRA AHMBA AI. ALMA_UNASSIGNED_HOLDINGS AOIJS ASPBG AVWKF AZFZN BAWUL BBAFP BBNVY BCR BCU BEC BENPR BHPHI BKEYQ BLC BPHCQ BVXVI CS3 D-I DIK DU5 E3Z EBD EBS EJD EMB EMOBN EX3 F5P FEDTE FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HVGLF HYE H~9 IAO IEA IHR IHW INH INR IOF IOV IPO IQODW ISR J5H K-O KQ8 L7B LK8 M0L M1P M5~ M7P MVM N4W N95 NAPCQ OBH OCB ODZKP OFXIZ OGEVE OHH OHT OK1 OVD OVIDX P2P P6G PQEST PQQKQ PQUKI PROAC PSQYO Q2X RPM S0X SJFOW SV3 TEORI TR2 TVE UHU UKHRP UMP VH1 VVN W2D WH7 WOQ WOW X7M XSB YFH YHG YKV YOC ZA5 ZGI ZXP ZY1 ~H1 ALIPV CCPQU CGR CUY CVF ECM EIF HMCUK ITC NPM AAYXX CITATION 7QP 7X8 5PM |
ID | FETCH-LOGICAL-c4100-bea9747f41a9044ef69d20ccc122a0482f0a9162e7b32da194b04a6fcb9bfdff3 |
IEDL.DBID | RPM |
ISSN | 0021-9738 |
IngestDate | Tue Sep 17 21:19:44 EDT 2024 Fri Oct 25 10:44:04 EDT 2024 Sat Oct 05 06:16:41 EDT 2024 Thu Sep 26 17:37:07 EDT 2024 Sat Sep 28 07:27:18 EDT 2024 Fri Nov 25 13:54:34 EST 2022 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Bile acid conjugate Chemotherapy Calcium Calcium calculus Hydroxyapatite In vitro Biological activity |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4100-bea9747f41a9044ef69d20ccc122a0482f0a9162e7b32da194b04a6fcb9bfdff3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | http://www.jci.org/articles/view/115430/files/pdf |
PMID | 1655828 |
PQID | 16143392 |
PQPubID | 23462 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_295595 proquest_miscellaneous_72133930 proquest_miscellaneous_16143392 crossref_primary_10_1172_JCI115430 pubmed_primary_1655828 pascalfrancis_primary_5404663 |
PublicationCentury | 1900 |
PublicationDate | 19911001 |
PublicationDateYYYYMMDD | 1991-10-01 |
PublicationDate_xml | – month: 10 year: 1991 text: 19911001 day: 1 |
PublicationDecade | 1990 |
PublicationPlace | Ann Arbor, MI |
PublicationPlace_xml | – name: Ann Arbor, MI – name: United States |
PublicationTitle | The Journal of clinical investigation |
PublicationTitleAlternate | J Clin Invest |
PublicationYear | 1991 |
Publisher | American Society for Clinical Investigation |
Publisher_xml | – name: American Society for Clinical Investigation |
References | 7378389 - Biochemistry. 1980 Apr 29;19(9):1983-8 6311382 - Calcif Tissue Int. 1983 Jul;35(4-5):596-601 111791 - Calcif Tissue Int. 1979 Mar 13;27(1):75-82 20204 - Calcif Tissue Res. 1977 Oct 20;23(3):259-69 534518 - Biochem J. 1979 Oct 15;184(1):181-4 4038261 - Biochem J. 1985 Jul 1;229(1):265-8 4367316 - Calcif Tissue Res. 1974 Jun 11;15(1):55-70 4319593 - Arch Biochem Biophys. 1970 Oct;140(2):318-25 2167763 - Calcif Tissue Int. 1990 Aug;47(2):112-6 7117791 - Gastroenterology. 1982 Nov;83(5):1079-89 2218581 - Semin Liver Dis. 1990 Aug;10(3):171-80 6090296 - Hepatology. 1984 Sep-Oct;4(5 Suppl):169S-172S 5077515 - Clin Sci. 1972 Sep;43(3):377-83 6853487 - J Biol Chem. 1983 May 25;258(10):6362-70 2295401 - Gastroenterology. 1990 Feb;98(2):444-53 4710793 - Calcif Tissue Res. 1973 May 9;12(2):143-58 3242951 - Chem Phys Lipids. 1988 Oct;48(3-4):231-43 6476378 - Anal Biochem. 1984 Jun;139(2):408-12 2592569 - J Clin Invest. 1989 Dec;84(6):1990-6 14001704 - Ann Surg. 1963 May;157:670-86 5568655 - Calcif Tissue Res. 1971;7(3):212-9 6282411 - Calcif Tissue Int. 1982 Mar;34(2):169-77 1212633 - Calcif Tissue Res. 1975 Dec 22;19(3):197-210 13945462 - Am J Physiol. 1962 Oct;203:671-5 6652554 - Calcif Tissue Int. 1983 Sep;35(6):783-90 9338 - Gut. 1976 Jul;17(7):506-10 187288 - Calcif Tissue Res. 1976 Dec 22;22(2):149-57 4674170 - Calcif Tissue Res. 1972;10(3):171-97 |
References_xml | |
SSID | ssj0014454 |
Score | 1.5214678 |
Snippet | Calcium hydroxyapatite can be a significant component of black pigment gallstones. Diverse molecules that bind calcium phosphate inhibit hydroxyapatite... Glycochenodeoxycholic acid (2 mM) totally inhibited transformation of amorphous calcium phosphate microprecipitates to macroscopic crystalline calcium... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1265 |
SubjectTerms | Biological and medical sciences Calcium - analysis Calcium Phosphates - chemistry Chemical Precipitation Digestive system Durapatite Fourier Analysis Glycochenodeoxycholic Acid - pharmacology Hydroxyapatites - chemistry Medical sciences Micelles Pharmacology. Drug treatments Taurocholic Acid - pharmacology |
Title | Glycochenodeoxycholic acid inhibits calcium phosphate precipitation in vitro by preventing the transformation of amorphous calcium phosphate to calcium hydroxyapatite |
URI | https://www.ncbi.nlm.nih.gov/pubmed/1655828 https://search.proquest.com/docview/16143392 https://search.proquest.com/docview/72133930 https://pubmed.ncbi.nlm.nih.gov/PMC295595 |
Volume | 88 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3BbtQwELVoJVClCkFL1QUKFuo13cRxnM0RrSilUqseqNRbZDs2cdW1o24WsT_EdzJ2vEu3Kheu8cSxPGP7jeblGaFjeDjJJNMJYZInVOgm4SXXiZhQTRQTgDgCQfaSnV3T85viJv4UNo-0SiuFObF3sxNr2sCt7GZyvOKJja8upsTLphXjLbQF8bnK0GPlgNIiKi9nSVXmk6gmBOf0-FYaLz6TpzvoecYKXzDaOI12Oz6HidHDjRZPQc7HzMkHR9HpK_QyYkj8eRjra_RM2T304iJWyffR7693S-lvwrKuUe5X2OGMxFyaBhvbGmH6OYYhSLOY4a51864FxIk7L3TRRc1uMMQ_TX_vsFj6lkCLtD8w4EXcPwC7YOk05jMH_nKLp7rt3fphu2w8a4Z7Fnev3qDr0y_fp2dJvI8hkTRL00Qo7rMPTTNepZQqzaqGpFLKjBAOOwHRKQe0SVQpctLwrKIipZxpKSqIAa3zA7RtnVWHCLOyBONcQW8KIFwjSAXITBRakVKoohqhTyu_1N0gu1GHdKUk9fn02-DGETra8NjaElAoBSQ1Qh9XHqxh0fhKCLcK5qIGmEtzQIb_toDEGAz8Nw4Gj_8dxhA5I8Q2QmHd7vW6N1sgjINu9xC2b__3xXdoJ_DUApPwPdru7xfqCBBRLz6EJfAHG3gUuA |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLVgCJg0Ib4myjZmIV6zJo7jNI-oYuvGOvGwSXuLbMdejFY7WlNE_xC_k2snLSsaL7zGN47le22fq3tyjNAneDhKJNMRYZJHVOgq4jnXkRhRTRQTgDgCQfaCTa7o2XV23f8UNu9plVYKc2RvZ0fW1IFb2czkcMUTG36bjomXTcuGj9ETWK4xXeXofe2A0qzXXk6iIk9HvZ4QnNTD79J4-Zk03kZPE5b5ktHGebTT8DlMje7utHgIdP7Nnbx3GB2_RC96FIk_d6N9hR4p-xo9m_Z18jfo18ntUvq7sKyrlPsZ9jgjMZemwsbWRph2jmEI0ixmuKndvKkBc-LGS100vWo3GOIfpr1zWCx9SyBG2hsMiBG39-AuWDqN-cyBx9zioW5bt35YLyvPm-Gex92qt-jq-MvleBL1NzJEkiZxHAnFff6hacKLmFKlWVGRWEqZEMJhLyA65oA3icpFSiqeFFTElDMtRQFRoHW6i7ass-odwizPwThV0JsCEFcJUgA2E5lWJBcqKwbo48ovZdMJb5QhYclJeTY-7dw4QAcbHltbAg6lgKUG6HDlwRKWja-FcKtgLkoAujQFbPhvC0iNwcB_Y7fz-J9hdJEzQGwjFNbtXrF7swUCOSh3d4H7_n9fPETPJ5fT8_L89OLrHtoOrLXAK9xHW-3dQh0APmrFh7AcfgPBhBgO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VIqpKCPFVsYVSC3FNN3EcZ3NEC0tbaNUDlXqLbMcmRt0k6mZR9w_xOxk7ydJF5cI1njiWZ2y_0bw8A7zHh5NIcRNQrkTApCkCkQoTyAkzVHOJiMMTZM_58SU7vUqutmAy_AvjSftK2qPqen5U2dJzK5u5Gg88sfHF2ZQ62bRk3BRm_AAe4pIN-ZCn9_UDxpJefzkKsjSe9JpCeFqPfyjrJGjicBceRTxxZaONM-lxIxY4Paa71-I-4Pk3f_LOgTR7Ck96JEk-dCN-Blu6eg47Z32t_AX8-ny9Uu4-rKoudH3r9zmriFC2ILYqrbTtguAQlF3OSVPWi6ZE3EkaJ3fR9MrdaEh-2vamJnLlWjw5svpOEDWS9g7kRcvaEDGv0Wv18r5u23r9sFwVjjsjHJe71S_hcvbp2_Q46G9lCBSLwjCQWrgcxLBIZCFj2vCsoKFSKqJU4H5ATSgQc1KdypgWIsqYDJngRskMI8GYeA-2q7rSr4DwNEXjWGNvGoFcIWmG-EwmRtNU6iQbwbvBL3nTiW_kPmlJaX46PencOIKDDY-tLRGLMsRTIzgcPJjj0nH1EFFpnIscwS6LER_-2wLTYzRw39jrPP5nGF3kjIBvhMK63al2b7ZgMHv17i549__3xUPYufg4y7-enH95DbueuOaphW9gu71Z6gOESK1861fDb5v8GSE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycochenodeoxycholic+acid+inhibits+calcium+phosphate+precipitation+in+vitro+by+preventing+the+transformation+of+amorphous+calcium+phosphate+to+calcium+hydroxyapatite&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Qiu%2C+S+M&rft.au=Wen%2C+G&rft.au=Hirakawa%2C+N&rft.au=Soloway%2C+R+D&rft.date=1991-10-01&rft.issn=0021-9738&rft.volume=88&rft.issue=4&rft.spage=1265&rft.epage=1271&rft_id=info:doi/10.1172%2FJCI115430&rft.externalDBID=n%2Fa&rft.externalDocID=10_1172_JCI115430 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon |